Form 4 for TELA TELA Bio, Inc.
Accepted 2025-11-17 00:00:00 ET · period of report 2025-11-17 · accession 0000908834-25-000358 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-17 | 2025-11-17 | TELA | EW Healthcare Partners Fund 2-UGP, LLC | 10%, See Remarks | P - Purchase | $1.11 | +3.60M | 7.71M | +88% | +$4.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.001 per share | 2025-11-17 | P | A | 3,604,000 | $1.11 | 7,714,709 | D | — | — | (F1) Shares of the Issuer's common stock acquired in the Issuer's underwritten registered direct offering at a price of $1.11 per share. Consists of 1,416,249 shares acquired by EW Healthcare Partners Fund 2, L.P. and 2,187,751 shares acquired by EW Healthcare Partners Fund 2-A, L.P. |